Serum superoxide dismutase levels of beta thalassemia patients and effects of high dosage of intravenous desferrioxamine treatment on superoxide dismutase levels

Pediatr Hematol Oncol. 1998 Jul-Aug;15(4):371-4. doi: 10.3109/08880019809014023.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Deferoxamine / therapeutic use*
  • Female
  • Humans
  • Infusions, Intravenous
  • Iron Chelating Agents / therapeutic use*
  • Male
  • Superoxide Dismutase / blood*
  • beta-Thalassemia / blood*
  • beta-Thalassemia / drug therapy

Substances

  • Iron Chelating Agents
  • Superoxide Dismutase
  • Deferoxamine